Skip to main content
Clinical Trials/CTRI/2020/02/023538
CTRI/2020/02/023538
Not yet recruiting
Phase 4

Comparison of efficacy and safety of fentanyl transdermal patch with oral ketorolac for pain management in dry socket.

Department Oral health sciences centre0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: PCS- Health Condition 2: R52- Pain, unspecified
Sponsor
Department Oral health sciences centre
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department Oral health sciences centre

Eligibility Criteria

Inclusion Criteria

  • 1\.Patients in the age group between 18\- 60 years.
  • 2\.Patients who will return to the clinic with symptoms and signs of dry socket, including moderate to severe pain with a VAS score \>4, will be included in this study.
  • 3\.Good physical and mental condition (ASA I ,II )
  • 4\.Absence of infection or trauma.
  • 5\.Patients in which Zinc Oxide Eugenol (ZNOE) dressing is given.
  • 6\.Patients who can understand English and Hindi Languages.

Exclusion Criteria

  • 1\.A history of allergy to the drugs used in the present study.
  • 2\.All pregnant and lactating females.
  • 3\.Alcohol or narcotics abusers.
  • 4\.Patients with ulcerative lesions or malignant lesions.
  • 5\.Patients who are taking monoamineoxidase inhibitor drugs.
  • 6\.Patients who are taking drugs for migraines.
  • 7\.Patients who are taking anti\-retroviral, antifungal drugs.
  • 8\.Patient who have acute (sudden) or severe asthma.
  • 9\.Patient who has a gastrointestinal problem called paralytic ileus.
  • 10\. Heart or respiratory failure

Outcomes

Primary Outcomes

Not specified

Similar Trials